Selecting a CDMO? Know your molecule, timeline

BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

About Subscribe Contribute

Upstream

Recent in Downstream

See all

thumbnail

Chromatography

Real-Time Monitoring of AAV CQAs in a Chromatographic Polishing Step Real-Time Monitoring of AAV CQAs in a Chromatographic Polishing Step

byBPI Contributor

Apr 9, 2024

1 Hr View

thumbnail

Chromatography

A Partnership in Innovation: Next-Generation Solutions for Affinity Chromatography A Partnership in Innovation: Next-Generation Solutions for Affinity Chromatography

byBPI Contributor

Mar 28, 2024

1 Hr View

Manufacturing

Recent in Manufacturing

See all

Monoclonal Antibody Productivity

Single Use

A Fully Single-Use Downstream Process for Monoclonal Antibodies A Fully Single-Use Downstream Process for Monoclonal Antibodies

byShunsuke Shiina, Neha Saxenaand 1 more

Apr 17, 2024

Artificial intelligence

Information Technology

Using Artificial Intelligence for Monoclonal Antibody Discovery Using Artificial Intelligence for Monoclonal Antibody Discovery

byWilliam Whitford

Apr 17, 2024

Analytical

Recent in Therapeutic Modalities

See all

Characterization methodologies

Emerging Therapeutics

Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars

bySanjib Banerjee, Rajiv Bharadwaj

Apr 17, 2024

Clean room worker using a computer

Emerging Therapeutics

The Evolution of Medicine: Empowering Healthcare for the Delivery of Advanced Therapies The Evolution of Medicine: Empowering Healthcare for the Delivery of Advanced Therapies

byRohin Iyer, Robert Brackner

Apr 10, 2024

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Facilities & Capacity

Lilly acquires Nexus plant to meet GLP-1 demand Lilly acquires Nexus plant to meet GLP-1 demand

byShreeyashi Ojha

Apr 24, 2024

2 Min Read

thumbnail

Deal Making

Ferring selects SK Pharmteco to manufacture gene therapy Ferring selects SK Pharmteco to manufacture gene therapy

byShreeyashi Ojha

Apr 24, 2024

2 Min Read

BPI Podcasts
Bioprocess Insider

Dan Stanton, Managing editor

September 12, 2022

With expertise in development and CMC in short supply globally, CDMO choice is absolutely critical for sponsors relying on them to accelerate development pathway, says Pharmatech Associates.

Ahead of November’s CPhI Worldwide event in Frankfurt, Germany, BioProcess Insider hosted a LinkedIn Live discussion with Bikash Chatterjee and Stephanie Gaulding, the respective CEO and MD at drug development consultancy firm Pharmatech Associates about current outsourcing strategies and how to go about selecting a CDMO partner.

Listen to the full discussion, as part of the BioProcess Insider Expression Platform, below, or at Spotify, Apple, or wherever you get your podcasts.

About the Author(s)

Dan Stanton

Managing editor

Journalist covering the international biopharmaceutical manufacturing and processing industries.

Founder and editor of Bioprocess Insider, a daily news offshoot of publication Bioprocess International, with expertise in the pharmaceutical and healthcare sectors, in particular, the following niches: CROs, CDMOs, M&A, IPOs, biotech, bioprocessing methods and equipment, drug delivery, regulatory affairs and business development.

From London, UK originally but currently based in Montpellier, France through a round-a-bout adventure that has seen me live and work in Leeds (UK), London, New Zealand, and China.

See more from Dan Stanton